Correction to “Immunogenic Nanovesicle‐Tandem‐Augmented Chemoimmunotherapy via Efficient Cancer‐Homing Delivery and Optimized Ordinal‐Interval Regime”
Source abstract
Abstract
In Figure 4g, the flow cytometry plot for "2.28%Th17 cells in spleen (S-PDNG)" was accidentally overlaid with the plot for "2.20% Th17 cells in spleen (PBS)" due to a formatting error in the image layout.The corrected version of the Figure is presented below: In Figure 4k, numerical labels for four data points (D7 (n1) of 1TP, D1 (n3) of 1PT, D7 (n3) of 1PT, and D22 (n1) of 7TP) were incorrectly inputted during the figure preparation process.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.